Through our NEST® technology, we are pioneering personalized, low energy brain stimulation for the treatment of Major Depressive Disorder and other diseases of the Central Nervous System (CNS).
NeoSync is committed to the advancement of research in this field, with completed, ongoing, and planned trials.
NeoSync is a clinical-stage company with a proprietary platform technology being used to develop advanced, non-invasive neuromodulation products.
CAUTION: NEST® is an investigational device and limited by federal (United States) law to Investigational Use
Copyright 2016. NeoSync, Inc.. All rights reserved.